TherapeuticsMD, Inc.
News
(2)April 2026
TherapeuticsMD, Inc. — 10-K/A Filing
# 📝 What This Document Is This is an **amended annual report** (Form 10-K/A) for TherapeuticsMD for the year ended December 31, 2025. It's being filed to fix printer errors in the original report. Crucially, it does **not** update any information since the original filing date (March 30, 2026). 👉
March 2026
TherapeuticsMD, Inc. — 10-K Filing
# 🧾 What This Document Is This is TherapeuticsMD's **annual report (Form 10-K)** for the year ended **December 31, 2025**. It's a mandatory, detailed filing with the SEC that gives a full picture of the company's business, financial condition, risks, and performance for the year. Think of it as the
Peers in Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Company Limited
Zoetis Inc.
Haleon plc
Teva Pharmaceutical Industries Limited
United Therapeutics Corporation
Viatris Inc.
Regencell Bioscience Holdings Limited
Neurocrine Biosciences, Inc.
Elanco Animal Health Incorporated
Dr. Reddy's Laboratories Limited